HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takehiko Kamijo Selected Research

PF 00477736

1/2020CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takehiko Kamijo Research Topics

Disease

25Neoplasms (Cancer)
02/2022 - 07/2003
14Neuroblastoma
06/2022 - 03/2007
3Neoplasm Metastasis (Metastasis)
04/2022 - 10/2018
3Lung Neoplasms (Lung Cancer)
01/2014 - 11/2008
2Chromosome Aberrations (Chromosome Abnormalities)
12/2021 - 10/2004
2Carcinogenesis
07/2017 - 06/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2015 - 11/2012
2Osteosarcoma (Osteogenic Sarcoma)
07/2010 - 02/2008
1Hepatomegaly
04/2022
1Carcinoma (Carcinomatosis)
02/2022
1Disease Progression
01/2021
1Papilloma (Papillomatosis)
01/2019
1Skin Neoplasms (Skin Cancer)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
08/2017
1Ataxia Telangiectasia (Louis Bar Syndrome)
05/2014
1Colonic Neoplasms (Colon Cancer)
01/2014
1Hepatoblastoma
11/2013
1Spontaneous Remission
06/2012
1Oligodendroglioma
07/2011
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2011
1Residual Neoplasm
03/2011
1Juvenile Myelomonocytic Leukemia
03/2011
1Hematologic Neoplasms (Hematological Malignancy)
09/2009
1Infections
02/2009
1Febrile Neutropenia
02/2009
1Starvation
02/2008
1Leukemia
02/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2005
1Bacterial Pneumonia
10/2004
1Staphylococcal Infections
10/2004

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2003
5Messenger RNA (mRNA)IBA
02/2022 - 07/2010
5DNA (Deoxyribonucleic Acid)IBA
12/2021 - 03/2007
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2010
4Biological ProductsIBA
06/2014 - 06/2012
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2021 - 01/2021
2AnionsIBA
08/2017 - 01/2014
2Peptides (Polypeptides)IBA
08/2017 - 01/2014
2Epidermal Growth Factor (EGF)IBA
07/2017 - 09/2012
2CarbonIBA
03/2015 - 11/2012
2Indicators and Reagents (Reagents)IBA
05/2014 - 11/2013
1Tumor Biomarkers (Tumor Markers)IBA
04/2022
1Hemoglobins (Hemoglobin)IBA
02/2022
1pembrolizumabIBA
02/2022
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1AlbuminsIBA
02/2022
1Ferritins (Ferritin)IBA
12/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1Biological FactorsIBA
01/2021
1PF 00477736IBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1Recombinant ProteinsIBA
12/2017
1Conditioned Culture MediaIBA
12/2017
1NeurocanIBA
12/2017
1Chondroitin Sulfate ProteoglycansIBA
12/2017
1AgarIBA
07/2017
1activin AIBA
07/2017
1hydrogen sulfite (bisulfite)IBA
06/2016
1GemcitabineFDA Link
03/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2014
1A-Form DNA (A-DNA)IBA
05/2014
1Anaplastic Lymphoma KinaseIBA
05/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2013
1Complementary DNA (cDNA)IBA
05/2013
1Leucine (L-Leucine)FDA Link
09/2012
1TensinsIBA
07/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2011
1Small Interfering RNA (siRNA)IBA
05/2011
1ChromatinIBA
05/2011
1Polycomb-Group ProteinsIBA
05/2011
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2011
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
12/2010
1Polycomb Repressive Complex 1IBA
07/2010
1Pharmaceutical PreparationsIBA
12/2009
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1fludarabineIBA
09/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2009
1VancomycinFDA LinkGeneric
02/2009
1Meropenem (Merrem)FDA LinkGeneric
02/2009
1PiperacillinFDA LinkGeneric
02/2009
1Carbapenems (Carbapenem Antibiotics)IBA
02/2009
1Anti-Bacterial Agents (Antibiotics)IBA
02/2009
1Cell Adhesion Molecule-1IBA
11/2008
1Immunoglobulins (Immunoglobulin)IBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
02/2008
1Cisplatin (Platino)FDA LinkGeneric
03/2007
1AntibodiesIBA
02/2007
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2005
1prednylidene (Pred)IBA
09/2005
1Prednisolone (Predate)FDA LinkGeneric
09/2005
1TeicoplaninIBA
10/2004

Therapy/Procedure

7Therapeutics
06/2022 - 08/2003
2Transplantation
02/2007 - 10/2004
1Induction Chemotherapy
10/2018
1Radiotherapy
10/2018
1Drug Therapy (Chemotherapy)
04/2012
1Hematopoietic Stem Cell Transplantation
09/2009
1Platelet Transfusion (Blood Platelet Transfusions)
02/2007